TY - JOUR
T1 - Methodology and reporting characteristics of studies using interrupted time series design in healthcare
AU - Hudson, Jemma
AU - Fielding, Shona
AU - Ramsay, Craig R.
N1 - This research did not receive any specific grant from funding agencies in the
public, commercial, or not-for-profit sectors for the design of the study and
collection, analysis, and interpretation of data and in writing the manuscript.
The Health Services Research Unit, University of Aberdeen, is core funded by
the Chief Scientist Office of the Scottish Government Health and Social Care
Directorates.
PY - 2019/7/4
Y1 - 2019/7/4
N2 - Randomised controlled trials (RCTs) are considered the gold standard when evaluating the causal effects of healthcare interventions. When RCTs cannot be used (e.g. ethically difficult), the interrupted time series (ITS) design is a possible alternative. ITS is one of the strongest quasi-experimental designs. The aim of this methodological study was to describe how ITS designs were being used, the design characteristics, and reporting in the healthcare setting.
AB - Randomised controlled trials (RCTs) are considered the gold standard when evaluating the causal effects of healthcare interventions. When RCTs cannot be used (e.g. ethically difficult), the interrupted time series (ITS) design is a possible alternative. ITS is one of the strongest quasi-experimental designs. The aim of this methodological study was to describe how ITS designs were being used, the design characteristics, and reporting in the healthcare setting.
KW - interrupted time series
KW - quasi-experimental
KW - healthcare interventions
KW - Healthcare interventions
KW - Quasi-experimental
KW - Interrupted time series
UR - https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-019-0777-x
UR - http://www.mendeley.com/research/methodology-reporting-characteristics-studies-using-interrupted-time-series-design-healthcare
UR - http://www.scopus.com/inward/record.url?scp=85068569788&partnerID=8YFLogxK
U2 - 10.1186/s12874-019-0777-x
DO - 10.1186/s12874-019-0777-x
M3 - Article
C2 - 31272382
VL - 19
JO - BMC Medical Research Methodology
JF - BMC Medical Research Methodology
SN - 1471-2288
M1 - 137
ER -